Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes
- Status
- UNKNOWN
- Phase
- NA
Clinical Study in the Treatment of Patients With COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)
- Status
- COMPLETED
- Phase
- N/A
(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
- Status
- UNKNOWN
- Phase
- NA
Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Macrophage Activation Markers in COVID-19 Patients
- Status
- COMPLETED
- Phase
- N/A
Protecting Native Families From COVID-19
- Status
- COMPLETED
- Phase
- NA
Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19
- Status
- COMPLETED
- Phase
- NA
Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3